Gene & Cell Therapy Imaging
Vector biodistribution and gene expression
Key Facts
About EMIT Imaging
EMIT Imaging is a private, early-revenue stage company founded in 2016 and based in Cambridge, Massachusetts. It has developed a proprietary preclinical imaging platform called Xerra™, which utilizes Cryo-Fluorescence Tomography (CFT) to bridge the resolution gap between cellular microscopy and whole-body imaging techniques like MRI and PET. The technology is positioned as a critical tool for advancing research in drug discovery, oncology, gene therapy, and neuroscience by providing definitive, quantitative 3D data on drug delivery and biological processes. The company operates on a hybrid business model, generating revenue from the sale of its instrumentation and by providing fee-for-service imaging to research organizations.
View full company profile